openPR Logo
Press release

Diabetes Devices Market Accelerated by CGM Adoption and Smart Insulin Tech Innovations | F. Hoffmann-La Roche Ltd, Abbott Laboratories, Medtronic plc, Terumo Corporation, B. Braun SE

06-28-2025 11:44 AM CET | Health & Medicine

Press release from: DataM intelligence 4 Market Research LLP

Diabetes Devices Market

Diabetes Devices Market

The Diabetes Devices market landscape is undergoing a transformative shift, driven by rapid technological advancements, evolving consumer behaviors, and intensifying competition across industries. This comprehensive market research report delivers in-depth insights, growth projections, and strategic analysis across key segments, empowering stakeholders with data-driven intelligence. Leveraging advanced analytics, trend forecasting, and competitive benchmarking, the report uncovers critical developments in innovation, emerging technologies, supply chain dynamics, and regulatory frameworks. Whether you're exploring investment opportunities, product development strategies, or expansion into high-growth regions, this report serves as your essential guide to navigating today's dynamic market environment.

Get exclusive insights with our detailed sample report (Corporate Email ID gets priority access): https://www.datamintelligence.com/download-sample/diabetes-devices-market?ophp

Diabetes Devices Market Growth

Diabetes Devices Market reached US$ 33.4 billion in 2024 and is expected to reach US$ 64.8 billion by 2033, growing at a CAGR of 7.7% during the forecast period 2025-2033.
In 2022, the Diabetes Devices Market was at US$ 29.39 Billion, and by 2023, it had

Comprehensive Insight into Diabetes Devices Market Landscape and Growth Trends:

Diabetes Devices include glucose monitors, insulin pumps, and CGMs that help manage blood sugar levels. The market is expanding rapidly due to the growing global diabetes burden, alongside tech-driven innovations in remote patient monitoring and wearable health tools.

Major Players Shaping the Competitive Landscape:

F. Hoffmann-La Roche Ltd, Abbott Laboratories, Medtronic plc, Terumo Corporation, B. Braun SE, Insulet Corporation, Nipro Corporation, Johnson & Johnson Services, Inc., Senseonics, Inc., Tandem Diabetes Care, Inc. and among others.

Important Mergers, Acquisitions, and Market Shifts:

✅ Cardinal Health announced in late 2024 (closing early 2025) the acquisition of Advanced Diabetes Supply Group (ADSG) for approximately $1.1 billion.

✅ In April 2025, Dexcom received FDA clearance for its upgraded G7 15‐Day continuous glucose monitor, offering extended sensor life (up to 15.5 days) and enhanced convenience. Dexcom's stock rose over 8% on the news

✅ Medtronic obtained FDA approval in November 2024 for its InPen app to support the upcoming Smart MDI system, integrating the app, InPen smart insulin pen, and Simplera CGM-bringing AI insights and dose corrections to patients on multiple daily injections

Speak to Our Analyst and Get Customization in the report as per your requirements: https://www.datamintelligence.com/customize/diabetes-devices-market?ophp

Methodology and Scope:

This Diabetes Devices Market report is developed using a robust research methodology that combines primary interviews, insights from industry experts, and verified secondary sources such as company filings, trade journals, and trusted databases. It follows a bottom-up and top-down approach to ensure data accuracy through triangulation. The scope of the report covers current market trends, growth potential, and strategic developments across global and regional markets.

Regional Overview for Diabetes Devices Market:

⇥ North America (U.S., Canada, Mexico)
⇥ Europe (U.K., Italy, Germany, Russia, France, Spain, The Netherlands and Rest of Europe)
⇥ Asia-Pacific (India, Japan, China, South Korea, Australia, Indonesia Rest of Asia Pacific)
⇥ South America (Colombia, Brazil, Argentina, Rest of South America)
⇥ Middle East & Africa (Saudi Arabia, U.A.E., South Africa, Rest of Middle East & Africa)

The Report Includes:

➡ A descriptive analysis of demand-supply gap, market size estimation, SWOT analysis, PESTEL Analysis and forecast in the global market.
➡ Go-to-market Strategy.
➡ Neutral perspective on the market performance.
➡ Customized regional/country reports as per request and country level analysis.
➡ Potential & niche segments and regions exhibiting promising growth covered.

People Also Ask:

➠ What are the global sales, production, consumption, imports, and exports in the Diabetes Devices market?
➠ Who are the top manufacturers, and what are their capacity, production, sales, pricing, and revenue stats?
➠ What key opportunities and challenges do vendors face in the Diabetes Devices industry?
➠ Which product types, applications, or end-users are driving market growth, and what is their market share?
➠ What are the major growth drivers and restraints of the Diabetes Devices market?

Looking For Exclusive Full Report? Get it here: https://www.datamintelligence.com/buy-now-page?report=diabetes-devices-market?ophp

Contact Us -
Company Name: DataM Intelligence
Contact Person: Sai Kiran
Email: Sai.k@datamintelligence.com
Phone: +1 877 441 4866
Website: https://www.datamintelligence.com

About Us -
DataM Intelligence is a Market Research and Consulting firm that provides end-to-end business solutions to organizations from Research to Consulting. We, at DataM Intelligence, leverage our top trademark trends, insights and developments to emancipate swift and astute solutions to clients like you. We encompass a multitude of syndicate reports and customized reports with a robust methodology.
Our research database features countless statistics and in-depth analyses across a wide range of 6300+ reports in 40+ domains creating business solutions for more than 200+ companies across 50+ countries; catering to the key business research needs that influence the growth trajectory of our vast clientele.

This release was published on openPR.

Permanent link to this press release:

Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.

You can edit or delete your press release Diabetes Devices Market Accelerated by CGM Adoption and Smart Insulin Tech Innovations | F. Hoffmann-La Roche Ltd, Abbott Laboratories, Medtronic plc, Terumo Corporation, B. Braun SE here

News-ID: 4085803 • Views:

More Releases from DataM intelligence 4 Market Research LLP

United States Hybrid Energy Storage Market Projected to Expand at 6.89% CAGR, Reaching USD 28.22 Billion by 2032 | DataM Intelligence
United States Hybrid Energy Storage Market Projected to Expand at 6.89% CAGR, Re …
The global Hybrid Energy Storage Market reached US$ 16.56 billion in 2024 and is projected to reach US$ 28.22 billion by 2032, growing at a CAGR of 6.89% during the forecast period 2025-2032, according to DataM Intelligence. United States: Recent Industry Developments ✅ In September 2025, Tesla launched its next-generation Megapack 2.0 with integrated lithium-ion and flow battery technology for grid-scale applications. ✅ In August 2025, The Department of Energy announced $2.1
United States Pyelonephritis Treatment Market Projected to Expand at 5.8% CAGR, Reaching USD 1.68 Billion by 2033 | DataM Intelligence
United States Pyelonephritis Treatment Market Projected to Expand at 5.8% CAGR, …
The global Pyelonephritis Treatment Market reached US$ 1,014.39 million in 2024 and is projected to reach US$ 1,682.83 billion by 2033, growing at a CAGR of 5.8% during the forecast period 2025-2033, according to DataM Intelligence. United States: Recent Industry Developments ✅ In September 2025, The FDA approved a new extended-release antibiotic formulation for complicated urinary tract infections, including pyelonephritis. ✅ In August 2025, CDC updated treatment guidelines for antibiotic-resistant pyelonephritis cases,
United States Uterine Cancer Treatment Market to Reach USD 39.0 Billion by 2033, Driven by Rising Incidence and Advancements in Targeted Therapies | DataM Intelligence
United States Uterine Cancer Treatment Market to Reach USD 39.0 Billion by 2033, …
The global Uterine Cancer Treatment Market reached US$ 23,633.46 Million in 2024 and is projected to reach US$ 39,007.22 Million by 2033, growing at a CAGR of 5.4% during the forecast period 2025-2033, according to DataM Intelligence. United States: Recent Industry Developments ✅ In September 2025, The FDA granted breakthrough therapy designation for Novartis' new targeted combination therapy for advanced endometrial cancer following promising Phase III trial results. ✅ In August 2025,
United States Medical Device Contract Manufacturing Market 2025 | Growth Drivers, Key Players & Investment Opportunities
United States Medical Device Contract Manufacturing Market 2025 | Growth Drivers …
Market Size and Growth The global medical device contract manufacturing market size reached US$ 76.43 Billion in 2024 from US$ 69.54 Billion in 2023 and is expected to reach US$ 190.88 Billion by 2033, growing at a CAGR of 10.9% during the forecast period 2025-2033. Key Development: United States: Recent Industry Developments ✅ In August 2025, Flex Ltd. expanded its medical device outsourcing services for U.S. clients, focusing on design, prototyping, and full-scale manufacturing. ✅

All 5 Releases


More Releases for Diabetes

Major Force in the Diabetes Pen Market 2025: Diabetes Fuels Surge In Demand For …
How Will the Diabetes Pen Market Grow, and What Is the Projected Market Size? The diabetes pen market is projected to grow from $29.24 billion in 2024 to $31.22 billion in 2025, at a CAGR of 6.8%. Growth is fueled by the rising need for managing diabetes, advancements in diabetes care, and an increasing focus on patient-friendly medication administration tools. The diabetes pen market is projected to grow strongly, reaching $40.17 billion
Diabetes Monitoring Devices Market: Regaining Its Glory| Ascensia Diabetes Care, …
The Latest Study Published by HTF MI Research on the "Diabetes Monitoring Devices Market'' evaluates market size, trend and forecast to 2029. The Diabetes Monitoring Devices market study includes significant research data and evidences to be a practical resource document for managers and analysts is, industry experts and other key people to have an easily accessible and self-analysed study to help understand market trends, growth drivers, opportunities and upcoming challenges
Prevalence of Diabetes Drives Opportunities for Type-2 Diabetes Market
The Type-2 Diabetes Market Analysis, 2023, by MarkNtel Advisors, presents a well-researched, detail-driven, and accurate study for the stakeholders. This analysis entails prominent aspects like trends, & recent developments, drivers, opportunities, challenges, & restraints, among other parameters, influencing the overall industry expansion across different locations. This report comprises data from historic years (2018-21) & the base year (2022) to put together an estimation of the forecast period (2023-28). According to Type-2 Diabetes Market
Reverse Diabetes with Dr. Merritt’s Diabetes Reversal Recipe
[November 26, 2020] – People suffering from diabetes always search for ways to lower blood sugar levels in their bodies. Diabetes treatment available costs you hundreds of dollars yearly and also restricts you to a diabetic diet. That hampers your mental health and well-being. Apart from this, eye problems, kidney failure, amputations are some of the physical problems diabetic patients face. Dr. Marlene Merritt (from the Merritt Wellness Center in
Diabetes Treatment
Diabetes Treatment is a important way to help manage the healthy ,easy to use and improve the way of the treatment of blood glucose monitoring system. As living standards improve, an increasing obesity, the Diabetes Treatment has improved peoples living habits, disease control effect, is becoming more and more important. The global Diabetes Treatment market is valued at 43700 million US$ in 2018 and will reach 58000 million US$ by the end
Self-Monitoring Blood Glucose Devices Market Study by Advance Application [Type …
The global self-monitoring blood glucose devices market was valued at $7,768 million in 2017 and is projected to reach $10,828 million by 2025 at a CAGR of 4.2% from 2018 to 2025. Monitoring of blood glucose is an essential step in diabetes management. Blood glucose monitoring devices are predominantly used to monitor a patient’s blood glucose level. Self-monitoring blood glucose (SMBG) devices are easy-to-use and enable people to monitor their